+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06590454

Study of Pyrvinium Treatment to Reverse High-Risk Gastric Intestinal Metaplasia and Precancer

Led by Katherine Garman · Updated on 2026-02-12

32

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating Pyrvinium versus a placebo for treating gastric intestinal metaplasia GIM with features linked to a higher risk of stomach cancer. This early Phase II clinical trial aims to assess safety and effectiveness by measuring changes in the extent and quality of GIM before and after treatment. The study also plans to create gastric organoids from patient samples to test Pyrvinium effects in the lab and explore new drugs to reverse GIM. The trial involves an initial observational screening endoscopy to document GIM using a standardized mapping protocol. About 60 participants will undergo this research endoscopy, and 32 eligible individuals with high-risk features will be randomized to receive either Pyrvinium or placebo. Treatment consists of a daily oral liquid dose of Pyrvinium 2 mgkg or placebo for 14 days, starting within three months of the initial endoscopy. Participants will use medication diaries and return medication bottles they are also advised to protect themselves from sun exposure due to possible sun sensitivity. During the study, participants will have endoscopies at baseline and 4 to 8 weeks later to evaluate changes in GIM through biopsies. Additional biopsy assessments will be performed at one year to monitor inflammation, atrophy reversal, and types of GIM. Safety and adherence will be tracked closely, and the primary measurement is the change in the number of biopsies showing gastric intestinal metaplasia between the screening and follow-up endoscopies. Overall participation includes screening, treatment, and follow-up assessments over one year.

CONDITIONS

Brief Title

REVerse Intestinal Metaplasia in the Stomach (REVISE)

Research Team

N

Nicole Pavlus

L

Laura Hayes, MS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here